Aptevo Therapeutics Inc (APVO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.41 +0.03 (+1.26%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.47 +0.06 (+2.49%) 16:44 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,130 | -17,818 | -12,717 | -6,834 | -17,411 |
| Depreciation Amortization | 352 | 281 | 197 | 106 | 567 |
| Accounts payable and accrued liabilities | -1,017 | -1,341 | -1,805 | -926 | 518 |
| Other Working Capital | -1,076 | -1,630 | -1,276 | -642 | 2,911 |
| Other Operating Activity | 2,086 | 2,482 | 2,797 | 1,645 | 1,685 |
| Operating Cash Flow | $-23,785 | $-18,026 | $-12,804 | $-6,651 | $-11,730 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -3,467 |
| Common Stock Issued | 15,599 | 8,879 | 3,970 | N/A | 9,475 |
| Other Financing Activity | -4 | -4 | -4 | -3 | -10 |
| Financing Cash Flow | $15,595 | $8,875 | $3,966 | $-3 | $5,998 |
| Beginning Cash Position | 16,904 | 16,904 | 16,904 | 16,904 | 22,636 |
| End Cash Position | 8,714 | 7,753 | 8,066 | 10,250 | 16,904 |
| Net Cash Flow | $-8,190 | $-9,151 | $-8,838 | $-6,654 | $-5,732 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,785 | -18,026 | -12,804 | -6,651 | -11,730 |
| Free Cash Flow | -23,785 | -18,026 | -12,804 | -6,651 | -11,730 |